BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9143476)

  • 1. Differences between technetium-99m tetrofosmin and technetium-99m sestamibi in parathyroid scintigraphy.
    Giordano A; Meduri G
    Eur J Nucl Med; 1997 Mar; 24(3):347. PubMed ID: 9143476
    [No Abstract]   [Full Text] [Related]  

  • 2. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
    Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
    J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
    Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-99m tetrofosmin. A new diagnostic tracer for parathyroid imaging.
    Ishibashi M; Nishida H; Kumabe T; Morita S; Matoba F; Nomura G; Hayabuchi N
    Clin Nucl Med; 1995 Oct; 20(10):902-5. PubMed ID: 8616997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid imaging with technetium-99m labelled cationic complexes: which tracer and which technique should be used?
    Lind P
    Eur J Nucl Med; 1997 Mar; 24(3):243-5. PubMed ID: 9143459
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
    Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radionuclide parathyroid imaging.
    O'Doherty MJ
    J Nucl Med; 1997 Jun; 38(6):840-1. PubMed ID: 9189126
    [No Abstract]   [Full Text] [Related]  

  • 8. Parathyroid scintigraphy: first experiences with technetium (III)-99m-Q12.
    Aigner RM; Fueger GF; Wolf G
    Eur J Nucl Med; 1997 Mar; 24(3):326-9. PubMed ID: 9143473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
    Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
    Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of Tc-99m sestamibi and Tc-99m tetrofosmin in a case of parathyroid adenoma.
    Mansi L; Rambaldi PF; Marino G; Pecori B; Del Vecchio E
    Clin Nucl Med; 1996 Sep; 21(9):700-3. PubMed ID: 8879870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid scintigraphy: comparison of technetium-99m methoxyisobutylisonitrile and technetium-99m tetrofosmin studies.
    Aigner RM; Fueger GF; Nicoletti R
    Eur J Nucl Med; 1996 Jun; 23(6):693-6. PubMed ID: 8662105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
    Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
    J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative comparison of technetium-99m tetrofosmin and thallium-201 images of the thyroid and abnormal parathyroid glands.
    Giordano A; Marozzi P; Meduri G; Ficola U; Calcagni ML; Vaccaro A; Rubini G; Attard M; Li Puma M; Ricci R; Corsello S
    Eur J Nucl Med; 1999 Aug; 26(8):907-11. PubMed ID: 10436206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
    Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
    Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Various dynamics of Tc-99m-tetrofosmin and Tc-99m-MIBI in a parathyroid adenoma].
    Nowak B; Sabri O; Hoff C; Reinartz P; Kleinhans E; Zimny M
    Nuklearmedizin; 1999; 38(5):160-3. PubMed ID: 10488484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
    Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
    J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m tetrofosmin parathyroid imaging in patients with primary hyperparathyroidism.
    Hiromatsu Y; Ishibashi M; Nishida H; Okuda S; Miyake I
    Intern Med; 2000 Feb; 39(2):101-6. PubMed ID: 10732824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient false-negative tc-99m sestamibi parathyroid scintigraphy following total thyroidectomy.
    Rubello D; Maffei P; Pelizzo MR; Martini C; De Carlo E; Piotto A; Rampin L; Shapiro B; Sicolo N
    Clin Nucl Med; 2005 Jul; 30(7):528-9. PubMed ID: 15965341
    [No Abstract]   [Full Text] [Related]  

  • 19. Localization of parathyroid glands using technetium-99m-tetrofosmin imaging.
    Ishibashi M; Nishida H; Strauss HW; Kojima K; Fujito H; Watanabe J; Hiromatsu Y; Hayabuchi N
    J Nucl Med; 1997 May; 38(5):706-11. PubMed ID: 9170432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [99m Tc-sestamibi in the diagnosis of the location of hyperparathyroidism].
    Berná Roqueta L
    Rev Esp Med Nucl; 1998; 17(2):102-11. PubMed ID: 9611280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.